I'm Andrew, founder and CEO of Axo Longevity, Europe's first consumer longevity platform. We combine AI-decoded biomarker testing, tracking, and personalized health blueprints into a yearly membership. Live in beta across the UK, Germany, Netherlands, and Spain with 1000+ locations.
Before Axo I worked in real estate finance and structured deals across the US and Mexico.
Ask me about building Axo, launching across five European markets, and AI-decoded biomarker testing.
By using this service, you agree to the Terms of Service and Privacy Policy.